European Moldmaker Launches U.S. Subsidiary

Dutch moldmaker IGS GeboJagema (Eindhoven) has created a U.S. subsidiary in Washington D.C. that will initially support its existing customer base in North America. IGS GeboJagema designs, manufactures and validates high-precision injection molds for medical and healthcare applications, including contact lenses, asthma inhalers, insulin pens and blood-diagnostic devices.

In March, IGS GeboJagema was acquired by European evergreen investment firm Smile Invest, purchasing the company from Nordian Capital, which itself had purchased the moldmaker in 2016. In November of last year, IGS GeboJagema announced record-breaking revenue of Euro 38 to 40 million in 2020. This January, it announced a series of investments at its production facility in Eindhoven, including a 280-ton Engel injection molding machine—its eighth press—as well as automated CMM systems, spark and wire EDM and 5-axis high-speed milling machines for cutting steel and manufacturing electrodes.

IGS GeboJagema will exhibit at MD&M East in December at booth 746.